Experimental and Computational Approaches to Identify Noncoding Pathogenic Variation in Rare Disease.

Area of Science:

• Genetics
• Genomics
• Developmental Biology

Background:

• Noncoding variants, found in noncoding genes and regulatory regions of protein-coding genes, are increasingly linked to developmental diseases.
• Interpreting the clinical significance of noncoding variants is difficult due to their unclear impact on gene expression compared to coding variants.
• Challenges in rare disease research include the inaccessibility of disease-relevant tissues for many conditions.

Purpose of the Study:

• To review current methods for identifying pathogenic noncoding variants in rare developmental diseases.
• To explore experimental and computational strategies for interpreting the functional impact of these variants.
• To propose an integrated approach for variant identification in affected patient cohorts.

Main Methods:

• Review of experimental approaches: high-throughput functional assays, omics data integration, and long-read sequencing.
• Review of computational methods: variant annotation, filtering, and machine learning for effect and pathogenicity prediction.
• Discussion of recent discoveries of developmental syndromes attributed to noncoding variants.

Main Results:

• Noncoding variants play a significant role in developmental diseases through various mechanisms.
• Established methods for variant interpretation face limitations, particularly with limited tissue availability.
• Advancements in functional assays, sequencing technologies, and computational tools are improving variant interpretation.

Conclusions:

• An integrated strategy combining experimental and computational methods is crucial for identifying pathogenic noncoding variants.
• Improved interpretation of noncoding variants will enhance diagnostic capabilities for rare developmental diseases.
• Further research into noncoding variant mechanisms can uncover novel therapeutic targets.